SEC Filing Details
Document Details
Form
Filing Date
May 2, 2022
Document Date
05/02/22
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.